Optimal treatment regimens for patients with bleeding disorders
- 1 May 2001
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 7 (3), 313-320
- https://doi.org/10.1046/j.1365-2516.2001.00525.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific EpistasisImmunity, 2000
- Management of haemophilia B patients with inhibitors and anaphylaxisHaemophilia, 1998
- Factor IX Inhibitors and Anaphylaxis in Hemophilia BJournal of Pediatric Hematology/Oncology, 1997
- Desmopressin and type II B von Willebrand diseaseHaemophilia, 1996
- The impact of prophylactic treatment on children with severe haemophiliaBritish Journal of Haematology, 1996
- Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large‐scale North American surveyHaemophilia, 1996
- Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrateHaemophilia, 1995
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992
- Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia AAmerican Journal of Hematology, 1984